NCT02195466View on ClinicalTrials.gov

Effects of Single-dose and Steady-state TPV/RTV on the Steady-state Pharmacokinetics of Fluconazole in Healthy Adult Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

June 30, 2003

Primary Completion Date

July 31, 2003

Conditions
Healthy
Interventions
DRUG

Tipranavir (TPV)

500 mg bid on days 7-14

DRUG

Ritonavir (RTV)

200 mg bid on days 7-14

DRUG

Fluconazole (FCZ)

200 mg loading dose on day 1, followed by 100 mg qd until day 13

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT02195466 - Effects of Single-dose and Steady-state TPV/RTV on the Steady-state Pharmacokinetics of Fluconazole in Healthy Adult Volunteers | Biotech Hunter | Biotech Hunter